tricalcium phosphate has been researched along with zoledronic acid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 16 (57.14) | 24.3611 |
| 2020's | 8 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, B; Bouler, JM; Bujoli, B; Daculsi, G; Faucheux, C; Gauthier, O; Grimandi, G; Guicheux, JJ; Janvier, P; Josse, S; Laïb, S; Massiot, D; Pilet, P; Soueidan, A | 1 |
| Bouler, JM; Bujoli, B; Gauthier, O; Guicheux, J; Janvier, P; Laïb, S; Peter, B; Pilet, P; Pioletti, DP; Zambelli, PY | 1 |
| Little, DG; Schindeler, A | 1 |
| Arshad, MD; Bouler, JM; Bujoli, B; Faucheux, C; Guicheux, J; Janvier, P; Josse, S; Pilet, P; Soueidan, A; Verron, E | 1 |
| Agis, H; Cvikl, B; Gruber, R; Moritz, A; Stögerer, K; Watzek, G | 1 |
| Bouler, JM; Bujoli, B; Despas, C; Fayon, F; Gauthier, O; Janvier, P; Khairoun, I; Massiot, D; Mellier, C; Montavon, G; Rouillon, T; Schnitzler, V; Walcarius, A | 1 |
| Abbruzzese, A; Caraglia, M; De Rosa, G; La Rotonda, MI; Leonetti, C; Marra, M; Porru, M; Salzano, G; Zappavigna, S | 1 |
| Greiner, S; Kadow-Romacker, A; Schmidmaier, G; Wildemann, B | 1 |
| Arnoldi, J; Procter, P; Robioneck, B; Sörensen, TC; Steckel, H | 1 |
| Hsu, LH; Lin, FH; Lu, DH; Wang, CC; Wu, CC; Yang, KC | 1 |
| Gou, J; Tang, X; Zhang, K | 1 |
| Liang, X; Liao, J; Liao, YM; Sun, NY; Teng, MH; Zang, CC; Zhai, JJ | 1 |
| Arnoldi, J; Beimel, C; Emanuelsson, L; Jönsson, A; Lennerås, M; Palmquist, A; Procter, P; Robioneck, B; Sörensen, TC; Steckel, H; Thomsen, P | 1 |
| Blanquer, M; Gonzálvez-García, M; Moraleda, JM; Oñate-Sánchez, R; Rodríguez-González, MA; Rodríguez-Lozano, FJ; Segarra-Fenoll, D; Villanueva, V | 1 |
| Feitosa, VP; Pashley, DH; Sauro, S; Seseogullari-Dirihan, R; Tay, FR; Tezvergil-Mutluay, A; Watson, TF | 1 |
| Arima, Y; Hashimoto, Y; Honda, Y; Li, P; Matsumoto, N | 1 |
| Ichikawa, K; Imai, Y; Mamoto, K; Minoda, Y; Mizokawa, S; Nakamura, H; Ohta, Y; Takaoka, K | 1 |
| Bigi, A; Boanini, E; Fini, M; Forte, L; Gazzano, M; Torricelli, P | 1 |
| Li, M; Lu, Y; Mao, C; Wan, P; Wang, W; Yang, K; Zhang, Y; Zhu, Y | 1 |
| Chowdhury, A; Karamched, SR; Nosoudi, N; Parasaram, V; Parrish, J; Siclari, S | 1 |
| Cheng, Y; Ji, QF; Liu, DZ; Liu, M; Mei, QB; Yang, Q; Zhou, SY | 1 |
| Aizawa, M; Honda, M; Kameda, Y; Sato, T | 1 |
| Aung, KT; Dang, AT; Hara, ES; Ishibashi, K; Kuboki, T; Mikai, A; Nawachi, K; Ono, M; Ono-Kimura, A; Oohashi, T; Tanaka, Y; Tosa, I | 1 |
| Aoki, K; Nakamura, M; Saito, N; Ueda, K; Yamamoto, Y; Yudasaka, M; Zhang, M | 1 |
| Ávila Souza, F; de Souza Rodrigues, LG; Hadad, H; Kawamata de Jesus, L; Maiorana, C; Marcantonio Junior, E; Milanezi de Almeida, J; Okamoto, R; Paolo Poli, P; Piquera Santos, AF; Pozzi Semeghini Guastaldi, F; Rinaldi Matheus, H | 1 |
| Cheng, Y; Ji, Q; Liu, B; Liu, D; Liu, M; Yang, Q; Yang, Z; Zhang, B; Zhou, S | 1 |
| Akhmedova, SA; Kaprin, AD; Karalkin, PA; Kirsanova, VA; Komlev, VS; Kuvshinova, EA; Nikitina, YO; Petrakova, NV; Sergeeva, NS; Sviridova, IK | 1 |
| Funayama, N; Imada, M; Kirita, T; Nakagawa, Y; Ueyama, Y; Yagyuu, T | 1 |
1 review(s) available for tricalcium phosphate and zoledronic acid
| Article | Year |
|---|---|
Bisphosphosphonate-calcium phosphate cement composite and its properties.
Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Drug Carriers; Drug Delivery Systems; Etidronic Acid; Humans; Pamidronate; Zoledronic Acid | 2019 |
27 other study(ies) available for tricalcium phosphate and zoledronic acid
| Article | Year |
|---|---|
Novel biomaterials for bisphosphonate delivery.
Topics: Animals; Biocompatible Materials; Bone Resorption; Calcium Phosphates; Cells, Cultured; Diphosphonates; Drug Carriers; Drug Implants; Imidazoles; Materials Testing; Osteoblasts; Rabbits; Surface Properties; Zoledronic Acid | 2005 |
Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration.
Topics: Animals; Calcium Phosphates; Diphosphonates; Drug Delivery Systems; Female; Imidazoles; Microscopy, Electron, Scanning; Osseointegration; Prostheses and Implants; Rats; Rats, Wistar; Titanium; Zoledronic Acid | 2005 |
Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Topics: 3T3 Cells; Animals; Bone Density Conservation Agents; Bone Substitutes; Calcium Phosphates; Cell Culture Techniques; Cell Differentiation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Imidazoles; Mice; Osteoblasts; Osteoclasts; Osteogenesis; Zoledronic Acid | 2005 |
Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
Topics: Animals; Apatites; Biocompatible Materials; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Cells, Cultured; Diphosphonates; Drug Carriers; Drug Delivery Systems; Imidazoles; Materials Testing; Osteoblasts; Osteoclasts; Rabbits; Zoledronic Acid | 2009 |
The response of dental pulp-derived cells to zoledronate depends on the experimental model.
Topics: Analysis of Variance; Bone Density Conservation Agents; Calcium Phosphates; Cell Culture Techniques; Cell Death; Cell Survival; Cells, Cultured; Dental Pulp; Diphosphonates; Humans; Imidazoles; Statistics, Nonparametric; Zoledronic Acid | 2011 |
Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.
Topics: Adsorption; Alendronate; Apatites; Bone Cements; Calcium Phosphates; Dielectric Spectroscopy; Diphosphonates; Hip Fractures; Imidazoles; Magnetic Resonance Spectroscopy; Osteoporotic Fractures; Time Factors; Zoledronic Acid | 2011 |
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
Topics: Animals; Antineoplastic Agents; Calcium Phosphates; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Drug Compounding; Humans; Imidazoles; Liposomes; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyethylene Glycols; Prostatic Neoplasms; Surface Properties; Tissue Distribution; Xenograft Model Antitumor Assays; Zoledronic Acid | 2011 |
Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro.
Topics: Bone Density Conservation Agents; Calcium Phosphates; Cells, Cultured; Diphosphonates; Humans; Imidazoles; In Vitro Techniques; Osteocalcin; Osteoclasts; Osteoprotegerin; RANK Ligand; Zoledronic Acid | 2013 |
Bone substitute materials delivering zoledronic acid: physicochemical characterization, drug load, and release properties.
Topics: Adsorption; Bone Density Conservation Agents; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Diphosphonates; Drug Carriers; Drug Delivery Systems; Humans; Imidazoles; Materials Testing; Microscopy, Electron, Scanning; Surface Properties; Zoledronic Acid | 2013 |
Calcium phosphate cement delivering zoledronate decreases bone turnover rate and restores bone architecture in ovariectomized rats.
Topics: Animals; Bone Cements; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Diphosphonates; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar; Treatment Outcome; Zoledronic Acid | 2012 |
Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers [WO2012042024].
Topics: Antineoplastic Agents; Calcium Phosphates; Cell Line, Tumor; Chemistry, Pharmaceutical; Diphosphonates; Drug Carriers; Humans; Imidazoles; Nanoparticles; Nanotechnology; Neoplasms; Patents as Topic; Phospholipids; Zoledronic Acid | 2012 |
[Zoledronic acid incorporated in chitosan/calcium phosphate ceramic: characterization and in vitro response of osteoblast cells].
Topics: Animals; Animals, Newborn; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cells, Cultured; Ceramics; Chitosan; Diphosphonates; Drug Carriers; Female; Imidazoles; Male; Osteoblasts; Rats; Rats, Sprague-Dawley; Zoledronic Acid | 2012 |
Locally enhanced early bone formation of zoledronic acid incorporated into a bone cement plug in vivo.
Topics: Animals; Bone Cements; Bone Regeneration; Calcium Phosphates; Diphosphonates; Gene Expression; Imidazoles; Male; Microscopy, Electron, Scanning; Osteogenesis; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Tibia; Zoledronic Acid | 2013 |
Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
Topics: Aged; Autografts; Biocompatible Materials; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Marrow Transplantation; Bone Matrix; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Mandibular Diseases; Multiple Myeloma; Platelet-Rich Plasma; Stem Cell Transplantation; Zoledronic Acid | 2013 |
Zoledronate and ion-releasing resins impair dentin collagen degradation.
Topics: Aluminum Compounds; Bone Density Conservation Agents; Calcium Compounds; Calcium Phosphates; Calcium Sulfate; Cathepsins; Collagen; Collagen Type I; Dentin; Diphosphonates; Edetic Acid; Humans; Hydrogen-Ion Concentration; Imidazoles; Materials Testing; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Peptides; Resin Cements; Saliva, Artificial; Silicates; Solubility; Spectroscopy, Fourier Transform Infrared; Tooth Demineralization; Zoledronic Acid | 2014 |
The Effect of Interferon-γ and Zoledronate Treatment on Alpha-Tricalcium Phosphate/Collagen Sponge-Mediated Bone-Tissue Engineering.
Topics: Animals; Biocompatible Materials; Bone Density Conservation Agents; Calcium Phosphates; Collagen; Diphosphonates; Guided Tissue Regeneration; Imidazoles; Interferon-gamma; Male; Osseointegration; Rats; Rats, Sprague-Dawley; Tissue Engineering; Tissue Scaffolds; Zoledronic Acid | 2015 |
Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2.
Topics: Animals; Bone Density Conservation Agents; Bone Development; Bone Morphogenetic Protein 2; Calcium Phosphates; Diphosphonates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Imidazoles; Male; Mice; Mice, Inbred ICR; Osteogenesis; Recombinant Proteins; Transforming Growth Factor beta; Treatment Outcome; Zoledronic Acid | 2016 |
Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study.
Topics: Calcium Phosphates; Cell Line; Coculture Techniques; Delayed-Action Preparations; Diphosphonates; Drug Evaluation, Preclinical; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Zoledronic Acid | 2017 |
Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.
Topics: Alloys; Apoptosis; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Calcium Phosphates; Cell Movement; Cytoskeleton; Diphosphonates; Giant Cell Tumor of Bone; Humans; Magnesium; Mitochondria; Neoplasm Metastasis; Neoplasms; NF-kappa B; Osteoclasts; Osteolysis; Oxidative Stress; Recurrence; Risk Factors; Signal Transduction; Strontium; Zoledronic Acid | 2018 |
Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer.
Topics: Antineoplastic Agents; Calcium Phosphates; Cell Line, Tumor; Docetaxel; Humans; Male; Nanoparticles; Polymers; Prostatic Neoplasms; Zoledronic Acid | 2021 |
Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment.
Topics: Animals; Bone Substitutes; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Drug Liberation; Humans; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Osteoclasts; Osteosarcoma; Zoledronic Acid | 2021 |
Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Cyclophosphamide; Diphosphonates; Disease Models, Animal; Female; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tooth Extraction; Transforming Growth Factor beta; Wound Healing; Zoledronic Acid | 2021 |
Bisphosphonate type-dependent cell viability suppressive effects of carbon nanohorn-calcium phosphate-bisphosphonate nanocomposites.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcium Phosphates; Carbon; Cell Survival; Diphosphonates; Drug Carriers; Ibandronic Acid; Mice; Nanocomposites; Osteoclasts; Pamidronate; Reactive Oxygen Species; Zoledronic Acid | 2022 |
Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Doxycycline; Photochemotherapy; Rats; Rats, Wistar; Saline Solution; Tooth Extraction; Zoledronic Acid | 2022 |
Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
Topics: Bone Marrow Diseases; Bone Neoplasms; Calcium Phosphates; Cell Line, Tumor; Docetaxel; Humans; Immunosuppression Therapy; Micelles; Osteolysis; Triple Negative Breast Neoplasms; Tumor Microenvironment; Zoledronic Acid | 2023 |
Functionalization of Octacalcium Phosphate Bone Graft with Cisplatin and Zoledronic Acid: Physicochemical and Bioactive Properties.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Cisplatin; Cytostatic Agents; Male; Zoledronic Acid | 2023 |
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Calcium Phosphates; Dental Care; Humans; Rats; Tooth Extraction; Zoledronic Acid | 2023 |